Opinion
Video
Author(s):
Sande Okelo, MD, leads a discussion on the updates in the GINA 2021 report regarding difficult-to-treat and severe asthma, as well as considerations for GINA Step 4 and 5 treatment approaches.
No Risk of Neuropsychiatric AEs With Montelukast Over LABA Agents for Asthma, Allergic Rhinitis
Checking in on the Lung Health Cohort Research Study
HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide
Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD
Low RSV Exposure In Childrens’ First Year Does Not Reduce Asthma Care Needs
Study Highlights Effect of Caffeine Intake While Pregnant on Childhood Asthma